How Trump's tariffs are reshaping Indian pharma | Mint

Last month, US President Donald Trump announced a tariff plan aimed at forcing generic drugmakers to relocate production to the United States. Under the proposal, imported generic medicines will remain duty-free until August 2028, before ta
Read more...